会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • NON-INVASIVE HUMAN CONDITION MONITORING DEVICE
    • 非侵入性人体状况监测装置
    • WO2017089479A1
    • 2017-06-01
    • PCT/EP2016/078707
    • 2016-11-24
    • ASTON UNIVERSITY
    • RAFAILOV, EdikSOKOLOVSKY, SergeiSIDOROV, Viktor Vasilyevich
    • A61B5/026A61B5/00
    • A61B5/0261A61B5/0071A61B5/418
    • A monitoring device capable of non-invasive simultaneous detection of flow properties of both red blood cells (RBC) and lymph contrast objects using Doppler flowmetry. Measure a combination of both blood microcirculation and lymph microcirculation is advantageous because can provide richer diagnostic information. The device comprises an infrared radiation source, a photodetector module for detecting a first and second signals that corresponding respectively to portions of an infrared pattern reflected from the biological tissue. The signals are analysed to determine Doppler shifts indicative of RBC flow velocity and lymph contrast object flow velocity. The device may also function as a fluorimeter, i.e. to excite and detect autofluorescent signals from biomarkers in irradiated tissue.
    • 一种能够使用多普勒流量计非侵入式同时检测红血细胞(RBC)和淋巴造影对象的流动特性的监测装置。 测量血液微循环和淋巴微循环的组合是有利的,因为可以提供更丰富的诊断信息。 该设备包括红外辐射源,用于检测分别对应于从生物组织反射的红外图案的部分的第一和第二信号的光电检测器模块。 分析信号以确定指示RBC流速和淋巴造影对象流速的多普勒偏移。 该装置还可以用作荧光计,即激发和检测来自受辐射组织中生物标志物的自体荧光信号。

    • 9. 发明申请
    • POROUS HIERARCHICAL SUBSTRATE
    • 多孔分层基板
    • WO2016135489A1
    • 2016-09-01
    • PCT/GB2016/050477
    • 2016-02-25
    • ASTON UNIVERSITY
    • LEE, Adam FraserPARLETT, Christopher Michael AndrewWILSON, Karen
    • B01J20/28C01B33/12B01J20/30B01J20/10
    • B01J20/103B01J20/28092B01J20/28097B01J20/3057C01B33/12
    • The present invention provides a method of producing a substrate comprising a porous network. The method comprises forming a substrate precursor containing an array of template particles; and removing the template particles from the substrate precursor using a solvent at a temperature below room temperature to yield the substrate. The present invention also provides a method of producing a substrate comprising a first porous network and a second porous network, the two porous networks being interconnected. The method comprises: forming a substrate precursor containing an array of first template particles and an array of second template particles; selectively removing the first template particles from the substrate precursor to form the first porous network; and subsequently removing the second template particles from the substrate precursor to form the second porous network.
    • 本发明提供一种生产包括多孔网络的基底的方法。 该方法包括形成含有模板颗粒阵列的底物前体; 并使用溶剂在低于室温的温度下从模板前体中除去模板颗粒,得到基材。 本发明还提供一种生产包括第一多孔网络和第二多孔网络的基底的方法,所述两个多孔网络互连。 该方法包括:形成含有第一模板颗粒阵列和第二模板颗粒阵列的衬底前体; 从所述衬底前体选择性地去除所述第一模板颗粒以形成所述第一多孔网络; 随后从衬底前体中除去第二模板颗粒以形成第二多孔网络。
    • 10. 发明申请
    • DIAGNOSTIC ASSAY AND TREATMENT FOR PREECLAMPSIA
    • 诊断和治疗前列腺炎
    • WO2016132136A1
    • 2016-08-25
    • PCT/GB2016/050408
    • 2016-02-18
    • ASTON UNIVERSITY
    • AHMED, AsifWANG, Keqing
    • G01N33/68A61K31/198
    • A61K31/198G01N33/689G01N2800/368A61K2300/00
    • The invention provides a method of diagnosis or prognosis of preeclampsia in a pregnant subject, comprising providing a sample from a pregnant subject and measuring the ratio between the amount of (a) one or both of sFlt-1 and PlGF, and (b) one or both of a breakdown product of heme and a breakdown product of arginine, in the sample. Also described are assay kits and a computer adapted for use in the method. Also described is a method of treating preeclampsia, comprising administering a pharmaceutically effective amount of L-arginine and/or citrulline and an inhibitor of arginase or pharmaceutically acceptable salts thereof. Also described is a method of treating cancer, comprising treating a subject with a therapeutically effective amount of an anti-VEGF compound, L-arginine and an arginase inhibitor.
    • 本发明提供了一种在怀孕受试者中诊断或预后的先兆子痫的方法,包括提供来自怀孕受试者的样品并测量sFlt-1和PlGF之一或两者的量之间的比例,和(b)一 或者样品中血红素的分解产物和精氨酸的分解产物两者。 还描述了测定试剂盒和适用于该方法的计算机。 还描述了治疗先兆子痫的方法,其包括施用药学有效量的L-精氨酸和/或瓜氨酸和精氨酸酶抑制剂或其药学上可接受的盐。 还描述了一种治疗癌症的方法,包括用治疗有效量的抗VEGF化合物L-精氨酸和精氨酸酶抑制剂治疗受试者。